TIF1γ 和 Smad4 在乳腺上皮细胞中对 EMT 的拮抗调节作用。
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.
机构信息
Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France; CNRS UMR5286, F-69000 Lyon, France; Centre Léon Bérard, F-69000 Lyon, France.
出版信息
EMBO Rep. 2011 Jul 1;12(7):665-72. doi: 10.1038/embor.2011.78.
Abstract
TGF-β is a potent inducer of epithelial-to-mesenchymal transition (EMT), a process involved in tumour invasion. TIF1γ participates in TGF-β signalling. To understand the role of TIF1γ in TGF-β signalling and its requirement for EMT, we analysed the TGF-β1 response of human mammary epithelial cell lines. A strong EMT increase was observed in TIF1γ-silenced cells after TGF-β1 treatment, whereas Smad4 inactivation completely blocked this process. Accordingly, the functions of several TIF1γ target genes can be linked to EMT, as shown by microarray analysis. As a negative regulator of Smad4, TIF1γ could be crucial for the regulation of TGF-β signalling. Furthermore, TIF1γ binds to and represses the plasminogen activator inhibitor 1 promoter, demonstrating a direct role of TIF1γ in TGF-β-dependent gene expression. This study shows the molecular relationship between TIF1γ and Smad4 in TGF-β signalling and EMT.
摘要
TGF-β 是上皮间质转化（EMT）的有效诱导剂，而 EMT 是肿瘤侵袭的一个过程。TIF1γ 参与 TGF-β 信号通路。为了理解 TIF1γ 在 TGF-β 信号通路中的作用及其 EMT 的必要性，我们分析了人乳腺上皮细胞系对 TGF-β1 的反应。TIF1γ 沉默的细胞在 TGF-β1 处理后 EMT 明显增加，而 Smad4 失活则完全阻断了这一过程。因此，通过微阵列分析，一些 TIF1γ 靶基因的功能可以与 EMT 相关联。TIF1γ 作为 Smad4 的负调节剂，对于 TGF-β 信号通路的调控可能至关重要。此外，TIF1γ 与纤溶酶原激活物抑制剂 1 启动子结合并抑制其表达，证明 TIF1γ 在 TGF-β 依赖性基因表达中具有直接作用。本研究显示了 TIF1γ 和 Smad4 在 TGF-β 信号通路和 EMT 中的分子关系。
相似文献
1
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.TIF1γ 和 Smad4 在乳腺上皮细胞中对 EMT 的拮抗调节作用。
EMBO Rep. 2011 Jul 1;12(7):665-72. doi: 10.1038/embor.2011.78.
2
miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.miR-130a-3p 通过调控 SMAD4 影响 TGF-β1 诱导的 EC-1 细胞上皮间质转化
Cancer Med. 2019 Mar;8(3):1197-1208. doi: 10.1002/cam4.1981. Epub 2019 Feb 11.
3
Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.丙戊酸通过上调 TIF1γ 抑制 TGF-β/Smad 信号通路抑制前列腺癌细胞上皮间质转化。
Eur J Pharmacol. 2019 Oct 5;860:172551. doi: 10.1016/j.ejphar.2019.172551. Epub 2019 Jul 16.
4
Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.SOX2对TIF1γ的抑制促进了非小细胞肺癌中转化生长因子-β诱导的上皮-间质转化。
Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.
5
Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.Tif1γ 对 TGF-β 信号的动态调控：一种计算方法。
PLoS One. 2012;7(3):e33761. doi: 10.1371/journal.pone.0033761. Epub 2012 Mar 23.
6
Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.白细胞介素-6 与转化生长因子-β1 相互作用在胆管癌上皮间质转化及化疗耐药中的作用。
Eur J Cancer. 2013 May;49(7):1725-40. doi: 10.1016/j.ejca.2012.12.002. Epub 2013 Jan 5.
7
TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.TIF1γ 蛋白通过作为转录调节剂 SnoN1 的小泛素样修饰酶（SUMO）E3 连接酶来调节上皮-间充质转化。
J Biol Chem. 2014 Sep 5;289(36):25067-78. doi: 10.1074/jbc.M114.575878. Epub 2014 Jul 24.
8
The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway.致癌基因 TBX3 是 TGF-β1 信号通路的下游靶标和介质。
Mol Biol Cell. 2013 Nov;24(22):3569-76. doi: 10.1091/mbc.E13-05-0273. Epub 2013 Sep 11.
9
OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.OVOL2拮抗TGF-β信号传导，以调控乳腺肿瘤转移过程中的上皮-间质转化。
Oncotarget. 2017 Jun 13;8(24):39401-39416. doi: 10.18632/oncotarget.17031.
10
Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.转化生长因子-β（TGF-β）诱导的整合素αvβ3表达增强是成纤维细胞生长因子1（FGF1）对TGF-β诱导的乳腺上皮细胞上皮-间质转化（EMT）增强作用所必需的。
PLoS One. 2015 Sep 3;10(9):e0137486. doi: 10.1371/journal.pone.0137486. eCollection 2015.
引用本文的文献
1
Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment.靶向E3泛素连接酶：特发性肺纤维化治疗的新前沿。
Front Immunol. 2025 Aug 18;16:1618424. doi: 10.3389/fimmu.2025.1618424. eCollection 2025.
2
Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer.三重基序家族蛋白（TRIMs）在乳腺癌中的新作用。
Cancer Med. 2024 Jul;13(14):e7472. doi: 10.1002/cam4.7472.
3
Prospects of circular RNAs: the regulators of drug resistance and metastasis in gastric cancer.环状RNA的前景：胃癌耐药性和转移的调节因子
Am J Transl Res. 2022 Aug 15;14(8):5760-5772. eCollection 2022.
4
A data-assimilation approach to predict population dynamics during epithelial-mesenchymal transition.一种数据同化方法，用于预测上皮-间充质转化过程中的种群动态。
Biophys J. 2022 Aug 16;121(16):3061-3080. doi: 10.1016/j.bpj.2022.07.014. Epub 2022 Jul 14.
5
Functional Roles of Bromodomain Proteins in Cancer.含溴结构域蛋白在癌症中的功能作用
Cancers (Basel). 2021 Jul 19;13(14):3606. doi: 10.3390/cancers13143606.
6
Consequences of Mutations and Abnormal Expression of SMAD4 in Tumors and T Cells.肿瘤和T细胞中SMAD4突变及异常表达的后果
Onco Targets Ther. 2021 Apr 13;14:2531-2540. doi: 10.2147/OTT.S297855. eCollection 2021.
7
Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development.乳腺癌数据集的全基因组规模荟萃分析确定了有前景的药物开发靶点。
J Biol Res (Thessalon). 2021 Feb 16;28(1):5. doi: 10.1186/s40709-021-00136-7.
8
Circ-OXCT1 Suppresses Gastric Cancer EMT and Metastasis by Attenuating TGF-β Pathway Through the Circ-OXCT1/miR-136/SMAD4 Axis.环状氧化辅酶A转运体1通过环状氧化辅酶A转运体1/微小RNA-136/信号转导分子4轴减弱转化生长因子-β信号通路来抑制胃癌上皮-间质转化和转移
Onco Targets Ther. 2020 May 11;13:3987-3998. doi: 10.2147/OTT.S239789. eCollection 2020.
9
Hepatic stellate cell-specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosis.肝星状细胞特异性敲除转录中介因子 1γ加重肝纤维化。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20190402.
10
Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis.中国癌症相关性肌炎患者的肌炎自身抗体分析
J Clin Lab Anal. 2020 Aug;34(8):e23307. doi: 10.1002/jcla.23307. Epub 2020 Mar 27.
本文引用的文献
1
TIF1gamma controls erythroid cell fate by regulating transcription elongation.TIF1γ 通过调控转录延伸控制红细胞命运。
Cell. 2010 Jul 9;142(1):133-43. doi: 10.1016/j.cell.2010.05.028.
2
Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo.Ectodermin/Tif1γ通过负调控 Smad 活性来调控哺乳动物胚胎的形成。
Development. 2010 Aug 1;137(15):2571-8. doi: 10.1242/dev.053801. Epub 2010 Jun 23.
3
Epithelial-mesenchymal transitions in development and disease.发育与疾病中的上皮-间质转化
Cell. 2009 Nov 25;139(5):871-90. doi: 10.1016/j.cell.2009.11.007.
4
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.TIF1γ的失活与Kras协同作用诱导胰腺囊性肿瘤。
PLoS Genet. 2009 Jul;5(7):e1000575. doi: 10.1371/journal.pgen.1000575. Epub 2009 Jul 24.
5
The basics of epithelial-mesenchymal transition.上皮-间质转化的基础知识。
J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104.
6
iNKT cell development is orchestrated by different branches of TGF-beta signaling.iNKT细胞的发育由转化生长因子-β信号传导的不同分支精心调控。
J Exp Med. 2009 Jun 8;206(6):1365-78. doi: 10.1084/jem.20090127. Epub 2009 May 18.
7
Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.转化生长因子-β信号传导至生长停滞、细胞凋亡及上皮-间质转化的机制。
Curr Opin Cell Biol. 2009 Apr;21(2):166-76. doi: 10.1016/j.ceb.2009.01.021. Epub 2009 Feb 23.
8
FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.FAM/USP9x是一种对转化生长因子β（TGFβ）信号传导至关重要的去泛素化酶，它控制Smad4单泛素化。
Cell. 2009 Jan 9;136(1):123-35. doi: 10.1016/j.cell.2008.10.051.
9
Generation of breast cancer stem cells through epithelial-mesenchymal transition.通过上皮-间质转化生成乳腺癌干细胞。
PLoS One. 2008 Aug 6;3(8):e2888. doi: 10.1371/journal.pone.0002888.
10
TGFbeta in Cancer.癌症中的转化生长因子β
Cell. 2008 Jul 25;134(2):215-30. doi: 10.1016/j.cell.2008.07.001.
Zotero 插件